Broker tips Suncorp (ASX:SUN) share price to shoot higher

Suncorp's shares could have room to climb…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Suncorp Group Ltd (ASX: SUN) share price has been on form in 2021.

Since the beginning of the year, the banking and insurance giant's shares have risen 28% to $12.59.

This means the Suncorp share price is now trading within sight of its 52-week high of $13.26.

A smartly-dressed businesswoman walks outside while making a trade on her mobile phone.

Image source: Getty Images

Where next for the Suncorp share price?

The good news for shareholders is that one leading broker not only believes the Suncorp share price can go higher, but also that it can make a new 52-week high.

According to a recent note out of Goldman Sachs, its analysts have a buy rating and $13.74 price target on the company's shares.

Based on the current Suncorp share price, this suggests that there's still 9% upside over the next 12 months before dividends.

In addition, the broker is forecasting a 61 cents per share fully franked dividend in FY 2022. Combined, this brings the total potential return to just under 14%.

What did the broker say?

Goldman Sachs was pleased with Suncorp's performance in FY 2021 and notes that it delivered earnings ahead of expectations.

And while it acknowledges that the Suncorp share price has rallied hard this year, it still sees enough value to maintain a buy rating.

Goldman explained: "While it is now harder to argue that SUN is cheap, we have nonetheless maintained our Buy rating, where we see good momentum in the business, plus near-term earnings risks as skewed positively."

There are four reasons why it believes the risks are skewed to the upside.

They are: "1) provided pressure does not mount on the industry to return recent motor frequency benefits, SUN will almost certainly record gains in 1H22 (potential for c.5% upside in EPS), 2) SUN's recent reserve development remains well above its normalised 1.5% release assumption and noted relative comfort in the outlook (GSe 1.5% assumed, and a result closer to FY21 experience would equate to c.3% upside), 3) scope for further banking collective provision release (A$60m of A$155m COVID overlay released in FY21), and 4) into FY23 if we were to calibrate to the mid-point of SUN's insurance margin targets alongside the bank cost/income ratio target we would see c.10% upside."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares

Brokers have been looking at these shares this week. Are they bullish?

Read more »

Coal miner holding a giant coal rock in his hand and making a circle with his other hand.
Broker Notes

What is this broker saying about New Hope Group shares?

Here's Bell Potter's guidance following earnings results.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

These ASX 200 shares have experienced significant falls over the past 12 months. Is there value here?

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

Read more »